These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10533345)

  • 1. Characteristics of pharmacies and pharmacists associated with the provision of cognitive services in the community setting.
    Christensen DB; Hansen RW
    J Am Pharm Assoc (Wash); 1999; 39(5):640-9. PubMed ID: 10533345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of a financial incentive on cognitive services: CARE project design/implementation.
    Christensen DB; Holmes G; Fassett WE; Neil N; Andrilla CH; Smith DH; Andrews A; Bell EJ; Hansen RW; Shafer R; Stergachis A
    J Am Pharm Assoc (Wash); 1999; 39(5):629-39. PubMed ID: 10533344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings.
    Raisch DW
    Ann Pharmacother; 1993 Oct; 27(10):1173-9. PubMed ID: 8251681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.
    Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
    J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand.
    Hansen RA; Roth MT; Brouwer ES; Herndon S; Christensen DB
    J Am Pharm Assoc (2003); 2006; 46(6):700-6. PubMed ID: 17176685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007.
    Look KA; Mott DA; Leedham RK; Kreling DH; Hermansen-Kobulnicky CJ
    J Manag Care Pharm; 2012 Mar; 18(2):116-28. PubMed ID: 22380471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provision of pharmaceutical care services in North Carolina: a 1999 survey.
    McDermott JH; Christensen DB
    J Am Pharm Assoc (Wash); 2002; 42(1):26-35. PubMed ID: 11833512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness.
    Svarstad BL; Bultman DC; Mount JK
    J Am Pharm Assoc (2003); 2004; 44(1):22-9. PubMed ID: 14965149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of community chain pharmacists' interventions on electronic prescriptions.
    Warholak TL; Rupp MT
    J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
    Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
    Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies.
    Ross-Degnan D; Soumerai SB; Goel PK; Bates J; Makhulo J; Dondi N; Sutoto ; Adi D; Ferraz-Tabor L; Hogan R
    Health Policy Plan; 1996 Sep; 11(3):308-18. PubMed ID: 10160376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and characteristics of cognitive services provided in response to a financial incentive.
    Christensen DB; Neil N; Fassett WE; Smith DH; Holmes G; Stergachis A
    J Am Pharm Assoc (Wash); 2000; 40(5):609-17. PubMed ID: 11029841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
    Isho NY; Kachlic MD; Marcelo JC; Martin MT
    J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan.
    Christensen DB; Roth M; Trygstad T; Byrd J
    J Am Pharm Assoc (2003); 2007; 47(4):471-83. PubMed ID: 17616493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do enhanced services pharmacies serve sicker patients?
    Urick BY; Farley JF
    J Am Pharm Assoc (2003); 2019; 59(2):280-284. PubMed ID: 30713081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing pharmacist-prescribed hormonal contraception services and users in California and Oregon pharmacies.
    Lu S; Rafie S; Hamper J; Strauss R; Kroon L
    Contraception; 2019 Apr; 99(4):239-243. PubMed ID: 30562478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.